NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ·Healthcare·Biotechnology
$27.30
-0.71%
Mkt Cap $3.26B
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (12 analysts)
$48.00
Range $45.00 – $51.00
Implied Upside
+75.8%
Consensus $48.00 vs current $27.30
NASDAQ·Healthcare·Biotechnology
$27.30
-0.71%
Mkt Cap $3.26B
Buy
3
Hold
0
Sell
0
Price Target (12 analysts)
$48.00
Range $45.00 – $51.00
+75.8%
Consensus $48.00 vs current $27.30